Si Y, Tian B, Zhang R, Xuan MD, Liu KY, Jiao J, Han SS, Li HF, Hu YH, Zhao HY, He WJ, Wang J, Liu T, Yu WF. IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression. World J Gastroenterol 2025; 31(46): 111631 [PMID: 41479643 DOI: 10.3748/wjg.v31.i46.111631]
Sheng Xu, Zheng Zhu, Pei-Hong Shi, Yue-Ting Xu, Hui-Ming Zhang, Yang Zheng, Yi-Tong Chen, Guang-Rong Lu, Bin-Jiao Zheng. Letter to the Editor: Targeting the <i>IGF2BP3</i>/<i>FBXO32</i>/cGMP-PKG axis as a therapeutic modality for gastric cancer: A promising strategy. World Journal of Gastroenterology 2026; 32(21): 116467doi: 10.3748/wjg.v32.i21.116467